A torn ACL (also known as the anterior cruciate ligament) is one of the most common knee injuries, with as many as 200,000 cases per year in the U.S. Young people under the age of 20 are at particular risk, in part because of participation in sports.
According to a presentation from the American Association of Neurological Surgeons Annual Scientific Meeting, optical topographic imaging is an efficient, novel technique that allows for initial and repeat registration of the cervical spine and had accuracy similar to other spinal neuronavigation systems.
Patients with inflammatory arthritis who underwent total hip arthroplasty experienced higher rates of complications compared with patients who had osteoarthritis, according to results.
Water on the knee is the layman’s term for a medical condition called knee effusion. Knee effusion is characterized by swelling of the knees, either in one or both legs, and knee pain. Knee effusion happens for one of three reasons: an injury, a disease or overusing the knees.
The surgical treatment helps in relieving pain and restoring the function of the joint after the damage. If you have pain in the knee joint, it can become difficult to perform daily activities. People who are over the age of 50 commonly seek this surgery due to wear and tear on the knee joint.
Do you suffer from knee pain? One can experience pricking pain on the inner side of the knee, joint instability, swelling, locking of the knee or redness. The severity of knee pain may vary from slightly achy to immobility. To get relief the source of the pain has to be identified.
If you suffer joint pain, not only will you constantly be uncomfortable, you will also suffer from mobility problems and may struggle with even the simplest of tasks. Experts have found that certain exercises and movements performed in water (i.e. a swimming pool) can help reduce joint pain and enhance mobility and flexibility.
A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1. The positive efficacy results from an ongoing research study were announced on Jan. 24 in a conference held by Asterias Biotherapeutics, Inc., the biotechnology company that manufactures AST-OPC1.